2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Gigantism: new trials by email Literature Review of Gigantism trials Research Report on Gigantism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs Debio 4126, Placebo - Acromegaly | Phase 3 | Recruiting | Debiopharm International SA | 119 | 2025-11-26 | 2026-10-23 |
| Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess Pegvisomant - Pituitary Disease | Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 12 | 2019-10-21 | 2025-11-06 |
| Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues Pasireotide LAR - Acromegaly | Phase 3 | Completed | Novartis Pharmaceuticals | 123 | 2015-03-31 | 2019-12-10 |
Acromegaly (2) · Pituitary Diseases (2) · Growth Disorders (1) · Pituitary Neoplasms (1)
Bone Diseases (3) · Bone Diseases, Developmental (3) · Bone Diseases, Endocrine (3) · Brain Diseases (3) · Central Nervous System Diseases (3) · Endocrine System Diseases (3) · Hyperpituitarism (3) · Hypothalamic Diseases (3) · Musculoskeletal Diseases (3) · Nervous System Diseases (3) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Hypothalamic Neoplasms (1) · Neoplasms (1)
pasireotide (1) · pegvisomant (1)
Debiopharm International SA (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Novartis Pharmaceuticals (1)
Belgium (2) · Brazil (2) · Bulgaria (2) · France (2) · Hungary (2) · Italy (2) · Romania (2) · United Kingdom (2) · United States (2) · Argentina (1) · Austria (1) · China (1) · Colombia (1) · Denmark (1) · Estonia (1)
2014 (1)